These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35218030)

  • 1. A novel bactericidal small molecule, STK-35, and its derivative, STK-66, as antibacterial agents against Gram-negative pathogenic bacteria in vitro and in vivo.
    She P; Xu L; Liu Y; Liu S; Li Z; Li Y; Hussain Z; Wu Y
    Lett Appl Microbiol; 2022 Sep; 75(3):655-666. PubMed ID: 35218030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design SMAP29-LysPA26 as a Highly Efficient Artilysin against Pseudomonas aeruginosa with Bactericidal and Antibiofilm Activity.
    Wang T; Zheng Y; Dai J; Zhou J; Yu R; Zhang C
    Microbiol Spectr; 2021 Dec; 9(3):e0054621. PubMed ID: 34878337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SAR investigation and optimization of benzimidazole-based derivatives as antimicrobial agents against Gram-negative bacteria.
    Dokla EME; Abutaleb NS; Milik SN; Kandil EAEA; Qassem OM; Elgammal Y; Nasr M; McPhillie MJ; Abouzid KAM; Seleem MN; Imming P; Adel M
    Eur J Med Chem; 2023 Feb; 247():115040. PubMed ID: 36584632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.
    Yao Q; Wang J; Cui T; Yang Z; Su M; Zhao P; Yan H; Zhan Y; Yang H
    Molecules; 2016 Jan; 21(1):62. PubMed ID: 26751436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ebselen bearing polar functionality: Identification of potent antibacterial agents against multidrug-resistant Gram-negative bacteria.
    Chen C; Yang K
    Bioorg Chem; 2019 Dec; 93():103286. PubMed ID: 31585265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane-active amino acid-coupled polyetheramine derivatives with high selectivity and broad-spectrum antibacterial activity.
    Li H; Li Y; Wang Y; Liu L; Dong H; Satoh T
    Acta Biomater; 2022 Apr; 142():136-148. PubMed ID: 35158080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of 1-((2,4-Dichlorophenethyl)Amino)-3-Phenoxypropan-2-ol, a Novel Antibacterial Compound Active against Persisters of Pseudomonas aeruginosa.
    Liebens V; Defraine V; Knapen W; Swings T; Beullens S; Corbau R; Marchand A; Chaltin P; Fauvart M; Michiels J
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From Breast Cancer to Antimicrobial: Combating Extremely Resistant Gram-Negative "Superbugs" Using Novel Combinations of Polymyxin B with Selective Estrogen Receptor Modulators.
    Hussein MH; Schneider EK; Elliott AG; Han M; Reyes-Ortega F; Morris F; Blastovich MAT; Jasim R; Currie B; Mayo M; Baker M; Cooper MA; Li J; Velkov T
    Microb Drug Resist; 2017 Jul; 23(5):640-650. PubMed ID: 27935770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining Colistin with Furanone C-30 Rescues Colistin Resistance of Gram-Negative Bacteria
    Zhang Y; Lin Y; Zhang X; Chen L; Xu C; Liu S; Cao J; Zheng X; Jia H; Chen L; Zhou T
    Microbiol Spectr; 2021 Dec; 9(3):e0123121. PubMed ID: 34730415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel
    Khan FM; Gondil VS; Li C; Jiang M; Li J; Yu J; Wei H; Yang H
    Front Cell Infect Microbiol; 2021; 11():637313. PubMed ID: 33738267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic Potentiation in Multidrug-Resistant Gram-Negative Pathogenic Bacteria by a Synthetic Peptidomimetic.
    Mood EH; Goltermann L; Brolin C; Cavaco LM; Nejad AJ; Yavari N; Frederiksen N; Franzyk H; Nielsen PE
    ACS Infect Dis; 2021 Aug; 7(8):2152-2163. PubMed ID: 34227804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic Effect of Combinations Containing EDTA and the Antimicrobial Peptide AA230, an Arenicin-3 Derivative, on Gram-Negative Bacteria.
    Umerska A; Strandh M; Cassisa V; Matougui N; Eveillard M; Saulnier P
    Biomolecules; 2018 Oct; 8(4):. PubMed ID: 30360557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathogens' distribution and changes of antimicrobial resistance in the bile of acute biliary tract infection patients].
    Wu ZY; Wu XS; Yao WY; Wang XF; Quan ZW; Gong W
    Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):24-31. PubMed ID: 33412630
    [No Abstract]   [Full Text] [Related]  

  • 14. Lysine-Based Small Molecule Sensitizes Rifampicin and Tetracycline against Multidrug-Resistant
    Konai MM; Haldar J
    ACS Infect Dis; 2020 Jan; 6(1):91-99. PubMed ID: 31646866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Antimicrobial Peptide LJ-hep2 from
    Gong R; An Z; Zhang W; Chen F; Wang KJ
    Mar Drugs; 2022 Oct; 20(10):. PubMed ID: 36286474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic activity between colistin and the ionic liquids 1-methyl-3-dodecylimidazolium bromide, 1-dodecyl-1-methylpyrrolidinium bromide, or 1-dodecyl-1-methylpiperidinium bromide against Gram-negative bacteria.
    Florio W; Rizzato C; Becherini S; Guazzelli L; D'Andrea F; Lupetti A
    J Glob Antimicrob Resist; 2020 Jun; 21():99-104. PubMed ID: 32298808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staphylococcal Bacterial Persister Cells, Biofilms, and Intracellular Infection Are Disrupted by JD1, a Membrane-Damaging Small Molecule.
    Dombach JL; Quintana JLJ; Detweiler CS
    mBio; 2021 Oct; 12(5):e0180121. PubMed ID: 34634935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity and in vivo animal model efficacy of IB-367 alone and in combination with imipenem and colistin against Gram-negative bacteria.
    Simonetti O; Cirioni O; Ghiselli R; Orlando F; Silvestri C; Mazzocato S; Kamysz W; Kamysz E; Provinciali M; Giacometti A; Guerrieri M; Offidani A
    Peptides; 2014 May; 55():17-22. PubMed ID: 24531033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial Activity of 1-[(2,4-Dichlorophenethyl)amino]-3-Phenoxypropan-2-ol against Antibiotic-Resistant Strains of Diverse Bacterial Pathogens, Biofilms and in Pre-clinical Infection Models.
    Defraine V; Verstraete L; Van Bambeke F; Anantharajah A; Townsend EM; Ramage G; Corbau R; Marchand A; Chaltin P; Fauvart M; Michiels J
    Front Microbiol; 2017; 8():2585. PubMed ID: 29312259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanding the potential of NAI-107 for treating serious ESKAPE pathogens: synergistic combinations against Gram-negatives and bactericidal activity against non-dividing cells.
    Brunati C; Thomsen TT; Gaspari E; Maffioli S; Sosio M; Jabes D; Løbner-Olesen A; Donadio S
    J Antimicrob Chemother; 2018 Feb; 73(2):414-424. PubMed ID: 29092042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.